Sientra (NASDAQ:SIEN) Rating Reiterated by Craig Hallum

Sientra (NASDAQ:SIENGet Free Report)‘s stock had its “hold” rating reiterated by investment analysts at Craig Hallum in a research report issued on Tuesday, Benzinga reports.

Separately, initiated coverage on shares of Sientra in a research note on Thursday, October 5th. They issued a “hold” rating for the company.

Read Our Latest Stock Report on SIEN

Sientra Stock Up 1.8 %

SIEN stock opened at $0.87 on Tuesday. The firm has a market cap of $9.77 million, a price-to-earnings ratio of -0.13 and a beta of 1.92. Sientra has a twelve month low of $0.59 and a twelve month high of $4.94. The business’s fifty day simple moving average is $2.12 and its two-hundred day simple moving average is $2.38.

Sientra (NASDAQ:SIENGet Free Report) last announced its quarterly earnings results on Thursday, August 10th. The medical instruments supplier reported ($0.85) EPS for the quarter, beating the consensus estimate of ($0.88) by $0.03. The firm had revenue of $23.13 million for the quarter, compared to analysts’ expectations of $25.00 million. Research analysts expect that Sientra will post -2.77 EPS for the current year.

Institutional Investors Weigh In On Sientra

Hedge funds and other institutional investors have recently bought and sold shares of the company. Mirabella Financial Services LLP acquired a new position in shares of Sientra during the first quarter worth $26,000. Advisor Group Holdings Inc. increased its position in Sientra by 230.9% during the 1st quarter. Advisor Group Holdings Inc. now owns 11,930 shares of the medical instruments supplier’s stock valued at $26,000 after buying an additional 8,325 shares in the last quarter. LPL Financial LLC purchased a new stake in Sientra in the second quarter valued at about $31,000. Virtu Financial LLC acquired a new stake in Sientra in the second quarter worth about $32,000. Finally, Wolverine Trading LLC purchased a new stake in shares of Sientra during the second quarter worth about $32,000. Hedge funds and other institutional investors own 15.38% of the company’s stock.

Sientra Company Profile

(Get Free Report)

Sientra, Inc, a medical aesthetics company, develops and sells medical aesthetics products in the United States and internationally. It offers silicone gel breast implants for use in breast augmentation and breast reconstruction procedures; breast tissue expanders; and scar management products under the Sientra Round, Sientra Teardrop, AlloX2, Dermaspan, Softspan, and BIOCORNEUM brand names.

Featured Stories

Receive News & Ratings for Sientra Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sientra and related companies with's FREE daily email newsletter.